Alcon Company Profile

✉ Email this page to a colleague

ALCON has fifty-seven approved drugs.

There are thirty-nine US patents protecting ALCON drugs. There is one tentative approval on ALCON drugs.

There are two hundred and seventeen patent family members on ALCON drugs in thirty-one countries and seventy-eight supplementary protection certificates in fourteen countries.

International Patents:	217
US Patents:	39
Tradenames:	48
Ingredients:	40
NDAs:	57
Patent Litigation for Alcon:	See patent lawsuits for Alcon
PTAB Cases with Alcon as patent owner:	See PTAB cases with Alcon as patent owner

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alcon Pharms Ltd	NAVSTEL	calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate	SOLUTION;IRRIGATION	022193-001	Jul 24, 2008		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Alcon Labs Inc	CYCLOGYL	cyclopentolate hydrochloride	SOLUTION/DROPS;OPHTHALMIC	084109-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Alcon	STATROL	neomycin sulfate; polymyxin b sulfate	SOLUTION/DROPS;OPHTHALMIC	050456-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Alcon	ECONOCHLOR	chloramphenicol	SOLUTION/DROPS;OPHTHALMIC	061645-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Alcon Labs Inc	SIMBRINZA	brimonidine tartrate; brinzolamide	SUSPENSION/DROPS;OPHTHALMIC	204251-001	Apr 19, 2013		RX	Yes	Yes	9,421,265	⤷ Try a Trial	Y			⤷ Try a Trial
Alcon Labs Inc	MYDRIACYL	tropicamide	SOLUTION/DROPS;OPHTHALMIC	084306-001	Approved Prior to Jan 1, 1982	AT	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Alcon Labs Inc	ROCKLATAN	latanoprost; netarsudil dimesylate	SOLUTION/DROPS;OPHTHALMIC	208259-001	Mar 12, 2019		RX	Yes	Yes	11,185,538	⤷ Try a Trial	Y			⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alcon Pharms Ltd	BETAXON	levobetaxolol hydrochloride	SUSPENSION/DROPS;OPHTHALMIC	021114-001	Feb 23, 2000	4,911,920*PED	⤷ Try a Trial
Alcon Pharms Ltd	NAVSTEL	calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate	SOLUTION;IRRIGATION	022193-001	Jul 24, 2008	7,084,130	⤷ Try a Trial
Alcon Labs Inc	PATADAY TWICE DAILY RELIEF	olopatadine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	020688-001	Dec 18, 1996	4,871,865	⤷ Try a Trial
Alcon Labs Inc	PATADAY ONCE DAILY RELIEF	olopatadine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	021545-001	Dec 22, 2004	5,641,805*PED	⤷ Try a Trial
Alcon	BSS PLUS	calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate	SOLUTION;IRRIGATION	018469-001	Approved Prior to Jan 1, 1982	4,443,432	⤷ Try a Trial
Alcon Pharms Ltd	BETAXON	levobetaxolol hydrochloride	SUSPENSION/DROPS;OPHTHALMIC	021114-001	Feb 23, 2000	5,540,918*PED	⤷ Try a Trial
Alcon Pharms Ltd	TRAVATAN	travoprost	SOLUTION/DROPS;OPHTHALMIC	021257-001	Mar 16, 2001	5,510,383	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Ophthalmic Solution	0.00%	➤ Subscribe	2008-11-28
➤ Subscribe	Ophthalmic Solution	0.03%	➤ Subscribe	2004-12-23

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0933372	13/2008	Austria	⤷ Try a Trial	PRODUCT NAME: FOSAMPRENAVIR ALS FOSAMPRENAVIR-CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001 - EU/1/04/282/002 (MITTEILUNG VOM 14.07.2004) 20040713
0933372	PA2008006,C0933372	Lithuania	⤷ Try a Trial	PRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712
1920764	12C0045	France	⤷ Try a Trial	PRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EU/1/01/199/001 20011127
1280520	122015000021	Germany	⤷ Try a Trial	PRODUCT NAME: TOBRAMYCIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/10/652/001-003 20110720
3461484	132021000000068	Italy	⤷ Try a Trial	PRODUCT NAME: COMBINAZIONE DI LATANOPROST E NETARSUDIL(ROCLANDA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1502, 20210108
1631293	2014/041	Ireland	⤷ Try a Trial	PRODUCT NAME: BRIMONIDINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTRATION NO/DATE: EU/1/13/904 20140221
0247633	62/1997	Austria	⤷ Try a Trial	PRODUCT NAME: ATORVASTATIN CALCIUM; NAT. REGISTRATION NO/DATE: 1-21926, 1-21927, 1-21928 19970411; FIRST REGISTRATION: GB PL 00018/0240 - PL 00018/0242 19961107
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.